Takeda logo

Oncology Leadership Team | Takeda Oncology

Global Oncology Leadership Team

Takeda’s Oncology Business Unit, which comprises Takeda’s global oncology commercial operations, works in close alignment with the Oncology Therapeutic Area Unit (OTAU), Takeda's dedicated global oncology R&D function. We are committed to working to address unmet patient needs, advancing our company's products, and expanding our oncology pipeline.

Meet our leadership team

Picture of Marcelo Barretta

Marcelo Barretta

Chief Financial Officer, Oncology Business Unit

VIEW BIO
Picture of Chris Braithwaite

Chris Braithwaite

Head of Data, Digital and Technology Global Oncology Business Unit

VIEW BIO
Picture of Kara Cournoyer

Kara Cournoyer

Head of Communications & Patient Advocacy, Global Oncology Business Unit

VIEW BIO
Picture of Annarita Egidi

Annarita Egidi

Head, Europe and Canada Oncology Business Unit

VIEW BIO
Picture of Pallavi Garg

Pallavi Garg

Head, U.S. Oncology Business Unit

VIEW BIO
Picture of Sascha Haverfield

Sascha Haverfield

Head, Strategy and Operations, Oncology Therapeutic Area Unit

VIEW BIO
Picture of John Huber, Ph.D.

John Huber, Ph.D.

Head, Global Regulatory Affairs, Oncology

VIEW BIO
Picture of Liz Lewis

Liz Lewis

Head, Global Oncology Pricing, Value & Access

VIEW BIO
Picture of Ryan MacLean

Ryan MacLean

Head of Human Resources, Global Oncology Business Unit

VIEW BIO
Picture of Rosa Notaroberto

Rosa Notaroberto

Head, Business Planning and Operations, Global Oncology Business Unit.

VIEW BIO
Picture of Tom Spalding

Tom Spalding

Head of Products, Pipeline and Strategy Global Oncology Business Unit

VIEW BIO